1Suppliers
6Customers
0Debt Items
0Related Chains

Source-Backed Evidence Depth

Anbio Biotechnology (NNNN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships
1Distinct source URLs
3High confidence
0.725Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Anbio Biotechnology Suppliers

TickerNameConfidenceEvidence
SUPPLIER SUPPLIER 90% For the year ended December 31, 2023, three suppliers accounted for 100% of the total purchases.

Anbio Biotechnology Customers

TickerNameConfidenceEvidence
CUSTOMER CUSTOMER 90% As of December 31, 2023, the balance due from four customers accounted for approximately 30%, 35%, 0%, and 19% of the Company’s total accounts receivable, respectively.
DELAWARE-PHARVAC-LIMITED-BRITISH-VIRGIN-ISLANDS- DELAWARE-PHARVAC-LIMITED-BRITISH-VIRGIN-ISLANDS- 62% o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th…
HONG-KONG-SAR-ANBIO-BIOTECHNOLOGY-PTY-LTD HONG-KONG-SAR-ANBIO-BIOTECHNOLOGY-PTY-LTD 62% o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th…
INCORPORATION-ANBIO-BIOTECHNOLOGY-LIMITED INCORPORATION-ANBIO-BIOTECHNOLOGY-LIMITED 62% o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th…
PRC-LOVIWELL-INC-BRITISH-VIRGIN-ISLANDS-LOVIWELL PRC-LOVIWELL-INC-BRITISH-VIRGIN-ISLANDS-LOVIWELL 62% o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th…
SAMOA-ANBIO-BIOTECHNOLOGY-LIMITED SAMOA-ANBIO-BIOTECHNOLOGY-LIMITED 62% o expand our marketing capabilities to increase our brand awareness and generate demand across our markets. Our global go-to-market strategy primarily follows business-to-business (“B2B”) approach th…

Anbio Biotechnology Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Anbio Biotechnology.

Anbio Biotechnology Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Anbio Biotechnology.

Anbio Biotechnology Ownership

HolderNameConfidenceEvidence
NNNN-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC GEODE CAPITAL MANAGEMENT, LLC 90% 13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 8 tracked holders.

Anbio Biotechnology Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
NNNN
Unlock NNNN Supply Chain Data
Verified relationships include:
SUPPLIERSUPPLIERSupplier90%
CUSTOMERCUSTOMERCustomer90%
DELAWARE-PHARVAC-LIMITED-BRITISH-VIRGIN-ISLANDS-DELAWARE-PHARVAC-LIMITED-…Customer62%
+4 more relationships locked
Subscribe, View plans →